| 10403307-e2f9-44d1-bc72-552fdba299d1 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | XLCare Pharmaceuticals Inc | Evaric Pharmaceuticals Inc | 20261102 |
| 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Macleods Pharmaceuticals Limited | 20261022 |
| 7d4f5cfa-35a8-1458-a609-f6b417946abb | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Apotex Corp. | 20261021 |
| 89eb2ffc-02d9-4b46-b480-e9b10af33027 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Stellon Biotech Inc. | CONCORD BIOTECH LIMITED | 20261016 |
| 6c33e5b4-4843-4a80-a4f8-435bfceddc2a | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | CONCORD BIOTECH LIMITED | 20261016 |
| 10403307-e2f9-44d1-bc72-552fdba299d1 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | XLCare Pharmaceuticals Inc | Evaric Pharmaceuticals Inc | 20261009 |
| 21a89264-8047-40ac-8b10-fa6461072509 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20261005 |
| ffa6819b-23a4-478b-8fb7-cc90e8142fc5 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Micro Labs Limited | 20260925 |
| ffa6819b-23a4-478b-8fb7-cc90e8142fc5 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Micro Labs Limited | 20260918 |
| 253635c8-1ea7-41ba-b216-dea5e3305c47 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 20260901 |
| 253635c8-1ea7-41ba-b216-dea5e3305c47 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 20260813 |
| 58f22c41-87d2-e745-e063-6394a90a962e | TOFACITINIB TABLETS. These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Golden State Medical Supply, Inc. | 20260813 |
| 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Macleods Pharmaceuticals Limited | 20260806 |
| 7d4f5cfa-35a8-1458-a609-f6b417946abb | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Apotex Corp. | 20260804 |
| ffa6819b-23a4-478b-8fb7-cc90e8142fc5 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Micro Labs Limited | 20260731 |
| 21a89264-8047-40ac-8b10-fa6461072509 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20260730 |
| 5751321a-c904-44ae-e063-6394a90a2654 | TOFACITINIB tablets, for oral use These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. Initial U.S. Approval: 2012 | AvKARE | 20260723 |
| 50962b08-99dd-ae73-e063-6394a90ad1eb | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 20260717 |
| 50962b08-99dd-ae73-e063-6394a90ad1eb | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 20260706 |
| 253635c8-1ea7-41ba-b216-dea5e3305c47 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 20260606 |
| 21a89264-8047-40ac-8b10-fa6461072509 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20260605 |
| 50962b08-99dd-ae73-e063-6394a90ad1eb | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 20260604 |
| ffa6819b-23a4-478b-8fb7-cc90e8142fc5 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Micro Labs Limited | 20260604 |
| 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Macleods Pharmaceuticals Limited | 20260603 |
| 2726c2b0-c763-4635-ac6b-4334c3a5a8bc | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Somerset Therapeutics, LLC | Bluepharma - Industria Farmaceutica, S.a. | 20260602 |
| 89eb2ffc-02d9-4b46-b480-e9b10af33027 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Stellon Biotech Inc. | CONCORD BIOTECH LIMITED | 20260530 |
| f4d0e580-74a8-496e-89a2-d74478c946bf | TOFACITINIB tablets, for oral use | Zydus Lifesciences Limited | 20260529 |
| 7d4f5cfa-35a8-1458-a609-f6b417946abb | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Apotex Corp. | 20260520 |
| c963c610-52e5-43ab-aac6-3f7e5341b764 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Breckenridge Pharmaceutical, Inc. | Towa Pharmaceutical Europe, S.L. | 20260514 |
| c963c610-52e5-43ab-aac6-3f7e5341b764 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Breckenridge Pharmaceutical, Inc. | Towa Pharmaceutical Europe, S.L. | 20260507 |
| 21a89264-8047-40ac-8b10-fa6461072509 | These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20260505 |
| f4d0e580-74a8-496e-89a2-d74478c946bf | TOFACITINIB tablets, for oral use | Zydus Lifesciences Limited | 20260505 |